⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3085854 | 0.98 | — | — | |
| SCHEMBL4230475 | 0.81 | — | — | |
| SCHEMBL5084449 | 0.68 | — | — | |
| SCHEMBL5078492 | 0.67 | — | — | |
| SCHEMBL5078493 | 0.66 | — | — | |
| SCHEMBL5080724 | 0.64 | — | — | |
| SCHEMBL11618156 | 0.64 | — | — | |
| SCHEMBL4382887 | 0.62 | — | — | |
| SCHEMBL19501757 | 0.62 | — | — | |
| SCHEMBL898668 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3221374-A1 | MOISTURE CURABLE COMPOSITIONS | Momentive Performance Materials Inc. (US) | 2017-09-27 | — | — | EP | disclosed |
| WO-2016081790-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-05-26 | — | — | WO | disclosed |
| US-20160136144-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2016-05-19 | — | — | US | disclosed |
| US-20140371260-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO. KGAA (GE) | 2014-12-18 | — | — | US | disclosed |
| CN-100339070-C | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | MERZ PHARMA GMBH & CO KGAA (DE) | 2007-09-26 | — | — | CN | disclosed |
| CN-1720035-A | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | MERZ PHARMA GMBH & CO KGAA (DE) | 2006-01-11 | — | — | CN | disclosed |
| US-6828462-B2 | Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists | MERZ PHARMA GMBH & CO. KGAA (DE) | 2004-12-07 | — | — | US | disclosed |